Skip to main content
Premium Trial:

Request an Annual Quote

Max Planck Society Investing $6.5M in New Chemical Genomics Center

NEW YORK, Jan. 27 (GenomeWeb News) - The Max Planck Society will provide €5 million ($6.5 million) over five years to support an interdisciplinary chemical genomics center that will search for therapeutically active compounds, the organization said yesterday.

 

Additional funding will be supplied by "pharmaceutical companies," the statement said.

 

The CGC will be housed in the Biomedical Centre Dortmund, near the Max Planck Institute for Molecular Physiology, and research will begin this summer, the Max Planck Society said.

 

Max Planck institutes participating in the center include: the Institute for Molecular Physiology; the Institute for Molecular Cell Biology and Genetics in Dresden; the Institute for Coal Research in M lheim; the Institute for Plant Breeding Research in Köln, the Institute for Psychiatry in M nich; and the Institute for Biochemistry in Martainsried.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.